MedPath

Survey and comparison of the efficacy of Granisetron and Promethazine in control of Hyperemesis Gravidarum

Not Applicable
Conditions
Hyperemesis gravidarum.
Hyperemesis gravidarum with metabolic disturbance
Registration Number
IRCT201108144927N2
Lead Sponsor
Aburaihan Pharmaceutical Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
120
Inclusion Criteria

the women in the 20 weeks of pregnancy; referred to gynecology and obstetrics emergency room in Dr.Shariati hospital; inappropriate response to outpatient antiemetic therapies; presenting more than one plus ketonuria in complete analysis of urine; nausea and vomiting score more than 13 (according to the pregnancy unique qualification of emesis) and signing the study written consent.
Exclusion criteria: molar pregnancy and sever thyroid or liver disease

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausea. Timepoint: 48 hours. Method of measurement: Physical examination.;Vomoting. Timepoint: 48 hours. Method of measurement: Physical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath